ItoY, MiyauchiA, InoueH, FukushimaM, KiharaM, HigashiyamaT, TomodaC, TakamuraY, KobayashiK, MiyaA. 2010. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg, 34:28–35.
2.
SugitaniI, TodaK, YamadaK, YamamotoN, IkenagaM, FujimotoY. 2010. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg, 34:1222–1231.
3.
OdaH, MiyauchiA, ItoY, YoshiokaK, NakayamaA, SasaiH, MasuokaH, YabutaT, FukushimaM, HigashiyamaT, KiharaM, KobayashiK, MiyaA. 2016. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid, 26:150–155.
4.
BritoJP, ItoY, MiyauchiA, TuttleRM. 2016. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid, 26:144–149.
5.
HaserGC, TuttleRM, SuHK, AlonEE, BergmanD, BernetV, BrettE, CobinR, DeweyEH, DohertyG, Dos ReisLL, HarrisJ, KlopperJ, LeeS, LevineRA, LeporeSJ, LikhterovI, LupoMA, MachacJ, MandelSJ, MechanickJI, MehraS, MilasM, OrloffL, RandolphG, RevensonTA, RobertsKJ, RossDS, RoweME, SmallridgeR, TerrisD, TufanoRP, UrkenML. 2016. Active surveillance for papillary thyroid microcarcinoma: new challenges and opportunities for the health care system. Endocr Pract, 22:22.
